Who should take the AREDS formulation?
People who are at high risk for developing advanced AMD should consider taking the formulation. You are at high risk for developing advanced AMD if you have either: 1. Intermediate AMD in one or both eyes. OR 2. Advanced AMD (dry or wet) in one eye but not the other eye. Your eye doctor can tell you if you have AMD, its stage, and your risk for developing the advanced form. The AREDS formulation is not a cure for Age-related Macular Degeneration. It will not restore vision already lost from the disease. However, it may delay the onset of advanced AMD. It may help people who are at high risk for developing advanced AMD to keep their vision.
• Answer: People who are at high risk for developing advanced AMD should consider taking the formulation. You are at high risk for developing advanced AMD if you have either: 1. Intermediate AMD in one or both eyes. OR 2. Advanced AMD (dry or wet) in one eye but not the other eye. Your eye care professional can tell you if you have AMD, its stage, and your risk for developing the advanced form. The AREDS formulation is not a cure for AMD. It will not restore vision already lost from the disease. However, it may delay the onset of advanced AMD. It may help people who are at high risk for developing advanced AMD keep their vision.
People who are at high risk for developing advanced AMD should consider taking the combination of nutrients used in the study. Your eye care professional can tell you if you have AMD and are at risk for developing the advanced form of the disease. The doctor should give you a dilated eye exam in which drops are placed in your eyes. This allows for a careful examination of the inside of the eye to look for signs of AMD.
People who are at high risk for developing advanced AMD should consider taking the formulation. You are at high risk for developing advanced AMD if you have either: 1. Intermediate AMD in one or both eyes. OR 2. Advanced AMD (dry or wet) in one eye but not the other eye. Your eye care professional can tell you if you have AMD, its stage, and your risk for developing the advanced form. The AREDS formulation is not a cure for AMD. It will not restore vision already lost from the disease. However, it may delay the onset of advanced AMD. It may help people who are at high risk for developing advanced AMD keep their vision. Can people with early stage AMD take the AREDS formulation to help prevent the disease from progressing to the intermediate stage? There is no apparent need for those diagnosed with early stage AMD to take the AREDS formulation. The study did not find that the formulation provided a benefit to those with early stage AMD.
